ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures
11. Dezember 2024 08:00 ET
|
ProPhase Labs, Inc.
The Company will review on Thursday, December 12th, at 12:00 p.m. EST. GARDEN CITY, NY, Dec. 11, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a...
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024
13. November 2024 08:00 ET
|
ProPhase Labs, Inc.
Highlights Q4 2024 and Q1 2025 with multiple potential liquidity events, growth in multiple subsidiaries as well as potentially significant reduction in overhead and expenses Company to hold a...
ProPhase Labs Announces Closing of Public Offering of Common Stock
12. November 2024 16:05 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and diagnostics company, today announced the...
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024
11. November 2024 09:52 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 11, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and diagnostics company, today announced that...
ProPhase Labs Announces Pricing of Public Offering of Common Stock
07. November 2024 23:37 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and diagnostics company, today announced the...
ProPhase Labs Announces Proposed Public Offering of Common Stock
07. November 2024 16:05 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next-generation biotech, genomics and diagnostics company, today announced that it intends to offer to sell...
ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry
04. November 2024 08:00 ET
|
ProPhase Labs, Inc.
Introduces DNA Expand Subscription Platform to Enrich Existing DNA Ancestry Data with Comprehensive Health Insights GARDEN CITY, NY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:...
ProPhase Labs to Present at the 2024 ThinkEquity Conference
22. Oktober 2024 08:00 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 22, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and diagnostics company, today announced...
ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025
17. Oktober 2024 08:00 ET
|
ProPhase Labs, Inc.
Projections for Pharmaloz Manufacturing: Approximately $16-17 Million in Revenue, $6-7 Million in Pre-Tax Earnings for 2025 Strategic Partnership Discussions Begin for BE-Smart Esophageal Cancer...
ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event
19. August 2024 11:10 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Aug. 19, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today announced...